News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReGen Biologics, Inc. (RGBI) Closes Bridge Financing


10/6/2009 8:51:24 AM

HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBO) announced today that it has entered into a bridge financing agreement for up to $3 million aggregate principal amount of secured convertible notes (“Notes”) and closed on the first tranche of the agreement with one of its principal investors. In the first closing under the bridge financing, the Company received $250,000 in immediately available funds and initial commitments for $1.5 million to be provided to the Company in increments to be established with the investors.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES